Navigation Links
Rattlesnake-type poisons used by superbug bacteria to beat our defenses
Date:9/7/2008

Colonies of hospital superbugs can make poisons similar to those found in rattlesnake venom to attack our bodies' natural defences, scientists heard today (Monday 8 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.

The toxins are manufactured by communities of the hospital superbug Pseudomonas aeruginosa called biofilms, which are up to a thousand times more resistant to antibiotics than free-floating single bacterial cells.

"This is the first time that anyone has successfully proved that the way the bacteria grow either as a biofilm, or living as individuals affects the type of proteins they can secrete, and therefore how dangerous they can potentially be to our health," says Dr Martin Welch from the University of Cambridge, UK.

"Acute diseases caused by bacteria can advance at an astonishing rate and tests have associated these types of disease with free-floating bacteria. Such free-floating bugs often secrete tissue-damaging poisons and enzymes to break down our cells, contributing to the way the disease develops, so it is natural to blame them. By contrast, chronic or long-term infections seem to be associated with biofilms, which were thought to be much less aggressive," says Dr Welch.

The research team's findings are very important to the NHS, which spends millions of pounds every year fighting chronic long-term bacterial infections which are incredibly difficult to treat.

"For example, these chronic infections by bacteria are now the major cause of death and serious disability in cystic fibrosis patients which is the most common lethal inherited disease in the UK and affects about 8,000 people," says Dr Welch.

In cystic fibrosis the gene defect means that people are very susceptible to a particular group of opportunistic bacteria including Pseudomonas aeruginosa, which is one of the three major hospital superbugs. Aggressive an
'/>"/>

Contact: Lucy Goodchild
l.goodchild@sgm.ac.uk
44-078-248-83010
Society for General Microbiology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Developing kryptonite for Superbug
2. Decoy makes sitting duck of superbugs
3. Green tea helps beat superbugs
4. New antibiotic beats superbugs at their own game
5. Shuttle brings space-grown strep bacteria back for study
6. The worlds oldest bacteria
7. Bacteria from sponges make new pharmaceuticals
8. Boston University biomedical engineers find chink in bacterias armor
9. University of Leicester scientists discover technique to help friendly bacteria
10. Spaceflight shown to alter ability of bacteria to cause disease
11. A tiny pinch from a z-ring helps bacteria cells divide

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...e California Institute of Technology (Caltech) hav...ehavior in the fruit fly, Drosophila melanogaster...e relationship between the neurotransmitter dopami...DHD), are described in the December issue of the j...ns only about 20,000 neurons and has long been con...
(Date:11/25/2009)... easy lives. In addition to mammalian immune syste...s called bacteriophages, viruses that kill half th...cteria and another class of microorganisms called ...such as deep-sea volcanic vents) manage just fine,...efense system that helps protect them from many vi...
(Date:11/25/2009)... Cell Death Research Laboratory in the University ... the prestigious Johnson & Johnson Focused Funding...in cell damage in Parkinson,s disease. The award, ...t of innovation and excellence in science, was ann...his month at an event at the Hyatt Regency Hotel i...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Armed Forces Retirement Home Selects Millenniums Pharmacy Services 50586 1Armed Forces Retirement Home Selects Millenniums Pharmacy Services 50586 2TrinityCare Senior Living Inc Information to be Available Through Standard 26 Poors Market Access Program 50582 1TrinityCare Senior Living Inc Information to be Available Through Standard 26 Poors Market Access Program 50582 2The Pennsylvania Breast Cancer Coalition Seeks Breast Cancer Survivors Throughout Pennsylvania 50578 1The Pennsylvania Breast Cancer Coalition Seeks Breast Cancer Survivors Throughout Pennsylvania 50578 2
...and construction can be significantly improved to ...help better resist high winds and hurricanes in re...chitecture professor Rima Taher, PhD. Taher, who ...e New Jersey School of Architecture. Courses taugh...uakes with guidelines and recommendations for bett...
... . Barcelona, Spain: For the first time in the...an embryonic stem cells (hESCs) from a single cell...h annual conference of the European Society of Hum...day 9 July). Dr. Hilde Van de Velde, from the Vrij...aid that their research meant that it might be pos...
...,Bulletin Board: BMRX), today announced that it ha...competitor, Sequiam Corporation. The company also,... those assets into the,company,s technology portfo...of which already are being sold under the company,...those assets is 44 Shares of Preferred,Stock plus ...
Other Biology News:NJIT architect professor advocates best-building practices for high wind regions 2Human embryonic stem cells developed from 4-cell embryo; world first may lessen ethical concerns 2Human embryonic stem cells developed from 4-cell embryo; world first may lessen ethical concerns 3Human embryonic stem cells developed from 4-cell embryo; world first may lessen ethical concerns 4bioMETRX, Inc. Completes Sequiam Asset Purchase 2
(Date:11/24/2009)..., , REYKJAVIK, Iceland, No...s, Inc. (Nasdaq: DCGN ) today announced that it ha...t trading in the company,s common stock will be,su...will be filed with the,Securities and Exchange Com...rom listing on Nasdaq, unless the company files an...
(Date:11/24/2009)..., , SAN MATEO, Calif., Nov. 24 /PRNewsw..., a biopharmaceutical company focused on developin...ies, announced today that Anthony DiTonno, Preside...esent at the 21st Annual Piper Jaffray Health Care...New York Palace Hotel in New York, New York. ,...
(Date:11/24/2009)..., , TSX VENTURE: HTL , TORONTO, Nov. ...TSX-V: HTL), formerly Calotto Capital Inc., a lead...ents for the stem cell research and fertility clin...al results for the third quarter ended September 3...ue was $1.46 million compared with $1.43 million i...
(Date:11/24/2009)... Program Connects Customer...amples Collected with DNA Genotek Products , ..., 2009 -- DNA Genotek , a leading provider of pro...ion and preparation, today announced its new globa...enhancements for DNA Genotek,s partner community a...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...(Nasdaq: PARS ) announced today that it has ente..., Reperio Pharmaceuticals Ltd. (Reperio) for the s...lated to the compound known as PRS-639,058 and som...noids are synthetic compounds which belong to the ...y fewer of the undesired psychotropic and cardiova...
...nologies, Inc. ("Senesco" or the "Company") (NYSE...ts for the three months ended December 31, 2008. ...ember 31, 2008 was $1,624,341, or $0.09 per share,...er share, for the three month period ended Decembe...ly the result of an increase in non-cash expenses ...
...recruitment events will be held on the nation,s co...ood, CO (Vocus) February 18, 2009 -- BioSpace.com,...ife science careers and industry resources, will h...r. These annual, networking opportunities attract ...eekers within the life sciences., , , , ,Biotech B...
Other Biology Technology:Pharmos Announces Agreement to Sell Certain CB2 Selective Agonists 2Pharmos Announces Agreement to Sell Certain CB2 Selective Agonists 3Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 2Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 3Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 4Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 5Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 6Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 7BioSpace.com Launches a New Season of Industry Career Fairs 2
Mouse Anti-Bovine collagen type IX Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Goat Anti-Mouse Nodal Polyclonal Antibody, Unconjugated from R&D Systems
Rat Anti-Mouse MMP-24 (MT5-MMP) Monoclonal Antibody, Unconjugated, Clone 143908 from R&D Systems
Prostaglandin E2 Luminex Standard from Cayman Chemical
Biology Products: